Results 141 to 150 of about 12,502 (244)

Comparative safety and efficacy of levosimendan versus dobutamine in acute heart failure: a systematic review, meta-analysis, and meta-regression. [PDF]

Ann Med Surg (Lond)
Raja A, Kumar L, Kumar M, Khurram L, Ali SME, Kumar N, Rao H, Mustafa I, Warisha S, Parvez M, Gulfaraz S, Saeed T, Saeed M, Sanober L, Tabasum, Abdullah, Ayalew BD, Chaulagain A.   +17 more
europepmc   +1 more source

Effects of Levosimendan in Patients with Severe Mitral Insufficiency and Left Ventricular Dysfunction Undergoing Transcatheter Edge-to-Edge Repair: A Systematic Review and Meta-Analysis. [PDF]

J Cardiovasc Dev Dis
Kühne SG, Patrignani A, Wölbert S, Harmel E, Penev D, Elvinger S, Chiarito M, Raake PWJ, Bongiovanni D.   +8 more
europepmc   +1 more source

Early cardiac rehabilitation supported by levosimendan infusion and mitral valve repair in acute myocardial infarction complicated by cardiogenic shock. [PDF]

Int J Cardiol Cardiovasc Risk Prev
Villaschi A, Di Lauro S, Calloni F, Toccafondi A, Oreglia J, Sacco A, Morici N.   +6 more
europepmc   +1 more source

Comparative Efficacy and Safety of Vasopressors and Inotropes in Acute Myocardial Infarction-Related Cardiogenic Shock: A Systematic Review and Network Meta Analysis of Randomized and Observational Studies. [PDF]

Cureus
Ali AOH, Ameer F, Ibrahim AA, Ali MS, Abdelhamid TA, Elmasry MH, Alrumaih F, Soliman KAR, Alghannami A, Abdalla SS, Hassan AA.   +10 more
europepmc   +1 more source

Population Pharmacokinetics of Levosimendan and its Metabolites OR-1855 and OR-1896 in Critically Ill Adults, Neonates and Infants on Veno-Arterial ECMO. [PDF]

Clin Pharmacokinet
Bertin S, Guidi M, Haefliger D, Thoueille P, Bardinet C, Decosterd LA, Perez MH, Giraud R, Assouline B, Schneider A, Buclin T, Livio F.   +11 more
europepmc   +1 more source

Efficacy of levosimendan for acute decompensated heart failure with preserved ejection fraction in the elderly: a single-center retrospective analysis. [PDF]

BMC Cardiovasc Disord
Xu X, Lv F, Xu C, Lai X.
europepmc   +1 more source

Clinical outcomes of levosimendan administration in veno-arterial extracorporeal membrane oxygenation: a meta-analysis. [PDF]

BMJ Open
Zhao GM, Zhao GM, Zhang H, Chen W, Zhou JX, Li HL.   +5 more
europepmc   +1 more source

Levosimendan in Decompensated Heart Failure with Reduced Ejection Fraction in Older Adults: A Systematic Review of Safety and Efficacy. [PDF]

Medicines (Basel)
Zavaleta-Monestel E, Mora-Jiménez J, Cruz-Mora K, Martinez-Vargas E, Díaz-Madriz JP, Arguedas-Chacón S, Fallas-Mora A, Wu-Chin C, Chaverrí-Fernandez JM.   +8 more
europepmc   +1 more source

A hypoxia-on-a-chip platform for modeling ischemic arrhythmogenesis and evaluating the effects of levosimendan and OR-1896 on ischemic human iPSC-derived cardiomyocytes. [PDF]

Front Bioeng Biotechnol
Gaballah M, Walls K, Zakzook F, Kreutzer J, Levijoki J, Aalto-Setälä K.   +5 more
europepmc   +1 more source

Levosimendan versus dobutamine in septic cardiomyopathy: a randomized clinical trial on cardiac function and safety. [PDF]

Front Cardiovasc Med
Zhao F, Wei H, Lin L, Wang H, Zhang Z, Guo L.   +5 more
europepmc   +1 more source